To further explore the potential clinical relevance of targeting the PI3K/Akt signaling in thyroid cancer, we directly examined the pAkt expression by Western blotting in a cohort of surgically resected patient PTC specimens and non-tumor thyroid tissues. The gene discussed is AKT1; the disease is thyroid gland carcinoma.